Intralipid Emulsion
Product Images NDC 0338-0520

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag 30 Pbp (Bag 30pbp)

Label for Intralipid 30% (30 g/100 mL) intravenous fat emulsion, 500 mL vial, labeled as a pharmacy bulk package not for direct infusion. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Image 2 (Inforuse30 Image2)

An instructional diagram showing hands removing the overwrap of a container by tearing at the notch and pulling down. The image highlights discarding the Oxalert sachet labeled A and the oxygen absorber labeled B. Instructions advise placing the bag on a clean, flat surface or hanging it on a support hook.*

FDA Label Image

Image 3 (Inforuse30 Image3)

An instructional illustration showing hands breaking off the tamper-evident arrow flag from the blue infusion port of a vial or container. The image is part of usage directions for handling the infusion port on the product.*

FDA Label Image

Image 4 (Inforuse30 Image4)

An instructional illustration showing hands holding the base of the infusion port and inserting a spike straight through the center of the septum by rotating the wrist. The image includes directions on assuring the spike is inserted straight and inspecting the bag for particulates or discoloration before use.*

FDA Label Image

Image 5 (Inforuse30p Image5)

An instructional illustration showing a hanging bag setup with two ports or connectors at the bottom. The accompanying text instructs to hang the bag in a hanger cut and start the transfer to the compounding bag. The image depicts step 5 in a procedural sequence.*

FDA Label Image

Figure 1 (Instruct Fig1)

An instructional illustration showing a container with two ports labeled A and B, accompanied by instructions to inspect the integrity indicator (Oxalert™) before removing the overwrap. The instruction states that if the indicator is black, the overwrap is damaged and the product should be discarded.*

FDA Label Image

Fatacid (Intralipid Figure 1 Fatacid Intralp)

Chemical structure diagram depicting the triglyceride lipid molecule consisting of a glycerol backbone esterified with three fatty acid chains (R1, R2, R3). This structure is associated with the active ingredient in Intralipid 30 g/100 mL by Baxter Healthcare Corporation.*

FDA Label Image

Phsph (Intralipid Figure 10 Phph Intrlp)

Chemical structure of the active ingredient in Intralipid 30 g/100mL, showing a triglyceride molecule with three fatty acid chains (R1, R2, R3) attached to a glycerol backbone.*

FDA Label Image

R1 (Intralipid Figure 11 2nd R1c Intrlp)

Chemical structure diagram showing a generic carbonyl group (C=O) with an attached R1 group on one side and an oxygen atom linked to another R group on the other side, typical of an ester functional group. The labels R1 and R represent variable side chains.*

FDA Label Image

R2 (Intralipid Figure 12 2 R2c)

Chemical structure diagram of the active ingredient, showing a molecule with labeled atoms including oxygen and carbon, featuring a methoxy group (OCH3).*

FDA Label Image

Phoscl (Intralipid Figure 13 Phosclne Intrlp)

Chemical structure of the active ingredient in Intralipid 30 g/100 mL by Baxter Healthcare Corporation, showing a complex lipid molecule with glycerol backbone, fatty acid esters, phosphate group, and choline moiety.*

FDA Label Image

Phosam (Intralipid Figure 14 Phosamn Intrlp)

Chemical structure of the active ingredient shown in the image. The diagram depicts a molecular structure with phosphate and ester functional groups, consistent with a lipid molecule.*

FDA Label Image

Hysyp (Intralipid Figure 15 Hygsyp Intrlp)

Chemical structure diagram depicting the molecular formula of the active ingredient in Intralipid 30 g/100mL by Baxter Healthcare Corporation. The structure shows a chain of carbon atoms with attached hydroxyl (OH) groups, representing a component related to Intralipid's formulation.*

FDA Label Image

R1c (Intralipid Figure 2 R1c Intralip)

Chemical structure diagram showing a generic molecular formula with a carboxyl group and an alkyl side chain denoted as R1 and R2. The image likely represents a fatty acid or lipid-related chemical structure, consistent with the active components in Intralipid 30 g/100mL by Baxter Healthcare Corporation.*

FDA Label Image

R2c (Intralipid Figure 3 R2c Intralip)

Chemical structure of Intralipid's active ingredient, depicting a generic R2C-C=O group representing a triglyceride or fatty acid component in the formulation.*

FDA Label Image

R3c (Intralipid Figure 4 R3c Intralp)

Chemical structure of the active ingredient represented by the formula R3C-C=O, indicating a generic carbonyl-containing compound. The image shows a molecular structure with unspecified R groups attached to the core carbonyl group.*

FDA Label Image

Linacd (Intralipid Figure 5 Linacid Intralp)

Chemical structure of Intralipid active components as depicted in the image, showing a complex arrangement of hydrocarbon chains and functional groups consistent with lipid molecules.*

FDA Label Image

Olacd (Intralipid Figure 6 Oleic Intrlp)

Chemical structure diagram of the active ingredient in Intralipid 30 g/100mL by Baxter Healthcare Corporation, showing the molecular arrangement of carbon, hydrogen, and oxygen atoms in the lipid molecule.*

FDA Label Image

Palacd (Intralipid Figure 7 Palacd Intralp)

Chemical structure diagram of Intralipid showing the fatty acid chain with carbon, hydrogen, and oxygen atoms, including a carboxyl group.*

FDA Label Image

Lncacid (Intralipid Figure 8 2nd Linacd Intrlp)

Chemical structure of the active ingredient in Intralipid 30 g/100mL, depicting a complex lipid molecule with multiple carbon, hydrogen, and oxygen atoms arranged in a detailed molecular configuration.*

FDA Label Image

Stracd (Intralipid Figure 9 Stear Intrlp)

Chemical structure of Intralipid's active ingredient, showing a lipid molecule with a long hydrocarbon chain ending in a carboxyl group (-COOH).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.